Review Article

Genetic Variants Associated with Thyroid Cancer Risk: Comprehensive Research Synopsis, Meta-Analysis, and Cumulative Epidemiological Evidence

Table 3

OR and P value for probable significant variants with insufficient data.

GeneVariantAllelesEthnicityMAF†StudiesNumber evaluationRisk of meta-analysisPQ
Sample size (case/control)Genetic modelsEffect modelOR (95%CI) valueI (%)

CYP1A2Frs762551A > CCaucasian0.442688 (170/518)RecessiveF1.921 (1.163 − 3.174)≤0.010.00.55
FTOrs1477196G > AOverall0.3222188 (1044/1144)AllelicF1.176 (1.037 − 1.334)≤0.0143.70.18
FTOrs8047395A > GOverall0.4222191 (1046/1145)AllelicR1.235 (1.009 − 1.511)0.0461.80.11
FTOrs11642841C > AOverall0.1822195 (1046/1149)AllelicF0.784 (0.653 − 0.941)≤0.0138.30.20
FTOrs17817288G > AOverall0.4422194 (1045/1149)RecessiveF1.410 (1.148 − 1.732)≤0.010.00.60
IL-18-127C-Trs360717C > TOverall0.342721 (130/591)AllelicF1.652 (1.192 − 2.288)≤0.0125.40.27
miR-608rs4919510G > CAsian0.4222975 (1193/1782)RecessiveF0.813 (0.664 − 0.997)0.050.00.40
TSHRrs1991517A > COverall0.2721239 (566/673)AllelicF1.250 (1.046 − 1.494)≤0.010.00.83
XRCC3rs56377012A > GAsian0.0721229 (459/770)RecessiveF9.421 (4.581 − 19.378)≤0.010.00.86

F: meta-analysis was performed under the fixed-effects model. R: meta-analysis was performed under the random-effects model. Overall: two or more ethnicities were reported in the study. †Frequency of minor allele in controls.